4//SEC Filing
Bolorforosh Said 4
Accession 0001127602-19-018739
CIK 0000313143other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:29 PM ET
Size
10.2 KB
Accession
0001127602-19-018739
Insider Transaction Report
Form 4
Bolorforosh Said
EVP, Chief Technology Officer
Transactions
- Award
Non-qualified Stock Option (Right to Buy)
2019-05-14+4,451→ 4,451 totalExercise: $98.03Exp: 2026-05-14→ Common Stock (4,451 underlying) - Award
Common Stock
2019-05-14+1,275→ 2,210 total
Footnotes (4)
- [F1]The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
- [F3]This number includes unvested RSUs previously reported.
- [F4]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001741776
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:29 PM ET
- Size
- 10.2 KB